Latest News

Legal/Regulatory

Ireland's drugmakers resist price cuts

The country's drug ministry has identified drugs as an area for savings.

Digital Google foresees a disease early warning system fostered by tiny particles

Google foresees a disease early warning system fostered by tiny particles

The company unveils a plan for deploying controllable nanoparticles into peoples' bodies for monitoring health conditions.

Pharmaceutical

Forbes's Matthew Herper sounds off on Viehbacher firing

Herper writes that Sanofi—without Viehbacher—is at risk of moving too slowly in an increasingly competitive industry.

Legal/Regulatory

India bans plastic packaging for drug liquids

Widely used plastics such as PET will have to be replaced with more costly glass containers.

Legal/Regulatory Make all Rx contraceptives OTC, lawyer urges FDA

Make all Rx contraceptives OTC, lawyer urges FDA

The former FDA director of medical device compliance has petitioned the agency to make oral contraceptives over-the-counter.

Pharmaceutical Five things for pharma marketers to know: Wednesday, October 29

Five things for pharma marketers to know: Wednesday, October 29

Sanofi CEO fired; Sovaldi sales slow; Ranbaxy CEO affirms generic Nexium rights.

Agency How Generations Y and Z Will Rock the Pink

How Generations Y and Z Will Rock the Pink

The next generations will engage with the digital world in a way that could effect real change in breast cancer.

Pharmaceutical

Pfizer undeterred from tax inversion deals

Despite the Treasury's crackdown on inversions, CEO Ian Read says they would still invert for the right deal.

Pharmaceutical

Amgen has no plans to split up, layoffs continue

The drugmaker plans to cut 600-1,100 jobs next year.

Pharmaceutical Diabetes competition muddles Sanofi's future, despite strong sales

Diabetes competition muddles Sanofi's future, despite strong sales

Sanofi is expected to slash prices of its diabetes products to retain US market access.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.